It had been almost a year since I had last visited pioneering cancer researcher Gordon Freeman in his office at Dana-Farber. On this blustery fall day I was using a cane, hoping that the reason for my limp and sore thigh was tendon and tissue strain, not new cancer or complications from treatment, recent surgery, and radiation.
The security guard in the lobby printed me a temporary ID card and pointed the way to the staff elevator that would take me to the fifth floor.
“You’ll have to swipe the ID once you get in the elevator,” she said. “Otherwise you won’t be able to get up there.” Continue reading Immunotherapy researcher Gordon Freeman takes stock